Table 1.
Demographics, intent-to-treat population
| LE ointment (n = 404) | Vehicle (n = 401) | Overall (n = 805) | |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 68.7 (9.26) | 69.2 (9.06) | 69.0 (9.16) |
| Minimum, maximum | 21, 92 | 38, 94 | 21, 94 |
| <65 | 116 (28.7%) | 105 (26.2%) | 221 (27.5%) |
| ≥65 | 177 (43.8%) | 185 (46.1%) | 362 (45.0%) |
| ≥75 | 111 (27.5%) | 111 (27.7%) | 222 (27.6%) |
| Gender | |||
| Male | 171 (42.3%) | 167 (41.6%) | 338 (42.0%) |
| Female | 233 (57.7%) | 234 (58.4%) | 467 (58.0%) |
| Race | |||
| White | 365 (90.3%) | 357 (89.0%) | 722 (89.7%) |
| Nonwhite | 39 (9.7%) | 44 (11.0%) | 83 (10.3%) |
Abbreviations: LE, loteprednol etabonate; SD, standard deviation.